CAS NO: | 343-27-1 |
包装 | 价格(元) |
5mg | 电议 |
10mg | 电议 |
20mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | Harmine Hydrochloride (Telepathine Hydrochloride) is a naturalDYRKinhibitor with anticancer and anti-inflammatory activities. Harmine has a high affinity of5-HT2Aserotonin receptor, with anKiof 397 nM[1]. | ||||||||||||||||
IC50& Target[1] |
| ||||||||||||||||
体外研究 (In Vitro) | Harmine inhibits tau phosphorylation by DYRK1A by selected DANDYs, with an IC50of 190 nM[2]. Harmine negatively regulates homologous recombination (HR) by interfering Rad51 recruitment, resulting in severe cytotoxicity in hepatoma cells. Furthermore, NHEJ inhibitor Nu7441 markedly sensitizes Hep3B cells to the anti-proliferative effects of Harmine[3]. | ||||||||||||||||
体内研究 (In Vivo) | It is shown that brain water content is significantly increased in the TBI group. Treatment with Harmine significantly reduces the tissue water content at 1, 3 and 5 days, compared with the TBI group. Harmine treatment significantly reduces the escape latency at 3 and 5 days, compared with the TBI group. Post-TBI administration of Harmine significantly improves the motor function recovery of the rats at 1, 3 and 5 days following TBI, compared with the TBI group without Harmine treatment. The neuronal survival rate in the Harmine-treated group is significantly increased, compared with the TBI group. Administration of Harmine results in marked elevation in the expression of GLT-1, compared with the TBI group. The administration of Harmine significantly reduces the expression of caspase 3, compared with the TBI group[4]. | ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 248.71 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C13H13ClN2O | ||||||||||||||||
CAS 号 | 343-27-1 | ||||||||||||||||
中文名称 | 哈尔碱盐酸盐 | ||||||||||||||||
结构分类 |
| ||||||||||||||||
来源 |
| ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) | ||||||||||||||||
溶解性数据 | In Vitro: H2O : 10 mg/mL(40.21 mM;ultrasonic and warming and heat to 60℃) DMSO : 5 mg/mL(20.10 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |